UOB:GETTEXUnited Overseas Bank Limited Analysis
Data as of 2026-05-30 - not real-time
€50.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
UOB shares are trading at €50, comfortably above the 20‑day SMA of €49.30 and the 50‑day SMA of €48.89, with the 200‑day SMA at €47.22 providing a solid long‑term support backdrop. The price sits just below the identified resistance of €50.5, while the RSI of 55.8 signals modest bullish momentum without being overbought. The MACD histogram is positive and the signal line is bullish, reinforcing the current upward trend, and the stock’s low beta of 0.39 suggests limited sensitivity to broader market swings. However, the 30‑day volatility of roughly 24% indicates price swings can be sizable, and trading volume is on a decreasing trend, which could constrain short‑term liquidity. On the valuation side, a PE of 13.5 sits well below the industry average of 16.6, and a dividend yield of 3.86% with a 64% payout ratio points to an attractive income profile.
Recent earnings disclosed a 4% drop in Q1 net profit amid rate headwinds, yet the bank beat expectations, highlighting resilience. Management’s ambition to double wealth‑management income by 2030 signals a clear growth narrative that could offset the modest revenue contraction observed. Combined, the technical strength, relative valuation discount, and dividend appeal make UOB a compelling candidate for investors seeking a blend of income and upside, while the profit dip and thinning volume counsel a measured approach.
Recent earnings disclosed a 4% drop in Q1 net profit amid rate headwinds, yet the bank beat expectations, highlighting resilience. Management’s ambition to double wealth‑management income by 2030 signals a clear growth narrative that could offset the modest revenue contraction observed. Combined, the technical strength, relative valuation discount, and dividend appeal make UOB a compelling candidate for investors seeking a blend of income and upside, while the profit dip and thinning volume counsel a measured approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance with bullish technical indicators
- Decreasing volume raising liquidity concerns
- Quarterly profit dip but earnings beat expectations
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to industry PE
- High dividend yield with sustainable payout
- Strategic wealth‑income growth target by 2030
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong capital base and low beta indicating stability
- Consistent dividend policy supporting total return
- Long‑term growth narrative in wealth management and regional banking
Key Metrics & Analysis
Financial Health
Revenue Growth-4.40%
Profit Margin39.84%
P/E Ratio13.5
ROE9.15%
P/B Ratio2.5
Industry P/E16.6
Technical Analysis
TrendBullish
RSI55.8
Support€47.60
Resistance€50.50
MA 20€49.30
MA 50€48.89
MA 200€47.22
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
GradeUndervalued
TypeBlend
Dividend Yield3.86%
Risk Assessment
Beta0.39
Volatility24.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.